Wall Street analyst estimates for NeurAxis, Inc. (NRXS): consensus price target, buy/hold/sell recommendations and forecasts for revenue, EPS and EBITDA for the upcoming fiscal years.
NeurAxis, Inc. (NRXS) is an American company specializing in neuromodulation therapy devices. Its primary offering is IB-Stim, a percutaneous electrical nerve field stimulation system engineered to alleviate functional abdominal pain associated with irritable bowel syndrome in patients aged 11 to 18. NeurAxis markets its solutions to healthcare providers, predominantly hospitals and clinics.
Recent Earnings Surprises
| Date | EPS Actual | EPS Est. | vs Est. |
|---|---|---|---|
| 2026-11-17 | $-0.21 | ||
| 2026-08-11 | $-0.19 | $-0.32 | +40.6% |
| 2026-05-12 | $-0.18 | $-0.19 | +5.3% |
| 2026-03-19 | $-0.17 | $-0.21 | +20.9% |
| 2025-11-10 | $-0.24 | $-0.20 | -20.0% |
| 2025-08-12 | $-0.22 | $-0.19 | -15.8% |
| 2025-05-12 | $-0.31 | $-0.24 | -29.2% |
| 2025-03-20 | $-0.21 | $0.04 | -625.0% |
Valuation Ratios
| Price / Book | 12.38 |
| EV / EBITDA | -8.76 |
| Dividend Yield | 0.00% |
Income Statement (10y)
| Year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | $1.9M | $2.7M | $2.7M | $2.5M | $2.7M | $3.6M |
| Cost of Revenue | $481089 | $467656 | $297060 | $303345 | $362002 | $562916 |
| Gross Profit | $1.4M | $2.3M | $2.4M | $2.2M | $2.3M | $3.0M |
| Research & Development | $166798 | $203414 | $225610 | $169315 | $206107 | $493611 |
| Selling, General & Admin | $5.4M | $5.0M | $5.5M | $8.7M | $9.3M | $10.3M |
| Operating Expenses | $5.6M | $5.2M | $5.8M | $8.8M | $9.5M | $10.8M |
| Operating Income | -$4.1M | -$3.0M | -$3.4M | -$6.7M | -$7.2M | -$7.8M |
| EBITDA | -$3.6M | -$3.0M | -$4.3M | -$9.2M | -$7.9M | -$7.7M |
| Interest Expense | $75711 | $36928 | $417601 | $5.4M | $300715 | $73969 |
| Pre-tax Income | -$3.7M | -$3.0M | -$4.8M | -$14.6M | -$8.2M | -$7.8M |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | -$3.7M | -$3.0M | -$4.8M | -$14.6M | -$8.2M | -$7.8M |
| EPS | $-0.80 | $-0.62 | $-0.57 | $-2.32 | $-1.22 | $-0.95 |
| EPS (Diluted) | $-0.80 | $-0.62 | $-0.78 | $-2.32 | $-1.22 | $-0.95 |
| Shares Outstanding (Diluted) | $5.4M | $5.4M | $8.4M | $6.3M | $6.9M | $9.1M |
Price
| Price | $6.94 |
| Market Cap | $87M |
| Exchange | AMEX |
| Country | US |
Related companies: CLGN · CVKD · ENLV · KLTO · NERV · NRSN · RLYB
Explore sector: Healthcare · Biotechnology
More sections of NRXS: Overview · Financials · Valuation · Statistics · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks